Sydney Tyson, MD, shares the take-home message from the presentation he delivered at the 2019 

American Society of Cataract and Refractive Surgery

 meeting: "Management of Ocular Inflammation and Pain Following Cataract Surgery with Dexamethasone 0.4 mg Insert (Dextenza, Ocular Therapeutix)."

Cataract

ASCRS

Your unrestricted view into eyecare conferences across the spectrum. Gain exclusive access to Ophthalmology Times® expert-led conference coverage from major meetings throughout the year featuring articles, videos, and insights shared by prominent experts of the ophthalmic community.

Conferences

ICMYI: Dr. Tyson shares his pearls using the dexamethasone 0.4 mg insert (Dextenza, Ocular Therapeutix).

Management of ocular inflammation and pain using novel insert